TNF-mediated cytotoxicity and resistance in human prostate cancer cell lines

Prostate

Volumn 29, Issue 5, 1996, Pages 296-302

  Nakajima, Yosuke ^a   DelliPizzi, Ann Marie ^a   Mallouh, Camille ^a   Ferreri, Nicholas R ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

interferon ; interleukin 6; prostate cancer; TNF receptor; tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

ANDROGENS; ANTIBODIES, MONOCLONAL; BINDING SITES; CELL DIVISION; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-6; MALE; PROSTATIC NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029852676     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199611)29:5<296::AID-PROS4>3.0.CO;2-8     Document Type: Article

References (22)

1. Nakajima Y, DelliPizzi A, Mallouh C, Ferreri NR: Effect of tumor necrosis factor-α and interferon-γ on the growth of human prostate cancer cell lines. Urol Res 23:205-210, 1995.
2. Vassalli P: The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411-452, 1992.
3. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM: Recombinant human tumor necrosis factor-α: Effects on proliferation of normal and transformed cells in vitro. Science 230:943-945, 1985.
4. Okamoto T, Watanabe N, Yamauchi N, Tsuji Y, Tsuji N, Itoh Y, Neda H, Niitsu Y: Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous necrosis factor. Cancer Res 52:5278-5281, 1992.
5. Safrit JT, Bonavida B: Sensitivity of resistant human tumor cell lines to tumor necrosis and adriamycin used in combination: Correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistance. Cancer Res 52:6630-6637, 1992.
6. Defilippi P, Poupart P, Tavernier J, Fiers W, Content J: Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor. Proc Natl Acad Sci USA 84:4557-4561, 1987.
7. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:16-23, 1979.
8. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF: Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21:274-281, 1978.
9. Muraki J, Addonizio JC, Choudhury MS, Fischer J, Eshghi M, Davidian MM, Shapiro LR, Wilmot PL, Nagamatsu GR, Chiao JW: Establishment of new human prostatic cancer cell line (JCA-1). Urology 36:79-84, 1990.
10. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP: LN-CaP model of human prostatic carcinoma. Cancer Res 43:1809-1818, 1983.
11. Bubenik J, Baresova M, Viklicky V, Jakoubkova J, Sainerova H, Donner J: Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer 11:765-773, 1973.
12. Rawle FC, Shields J, Smith SH, Iliescu V, Merkenschlager M, Beverley PCL, Callard RE: B cell growth and differentiation induced by supernatants of transformed epithelial cell lines. Eur J Immunol 16:1017-1019, 1986.
13. May LT, Viguett H, Kenney JS, Ida N, Allison AC, Sehgal PB: High levels of "complexed" interleukin-6 in human blood. J Biol Chem 267:19698-19704, 1992.
14. 3. Blood 70:994-1002, 1987.
15. Abe Y, Gatanaga M, Osuka Y, Kimura S, Burger RA, Granger GA, Gatanaga T: Role of 55- and 75-kDA tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. J Immunol 150:5070-5079, 1993.
16. Tartaglia LA, Rothe M, Hu YF, Goeddel DV: Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73:213-216, 1993.
17. Akira S, Hirano T, Taga T, Kishimoto T: Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 4:2860-2867, 1990.
18. Ruggiero V, Tavernier J, Fiers W, Baglioni C: Induction of the synthesis of rumor necrosis factor receptors by interferon-gamma. J Immunol 136:2445-2450, 1986.
19. Spriggs DR, Imamura K, Rodriguez C, Sariban E, Kufe DW: Tumor necrosis factor expression in human epithelial tumor cell lines. J Clin Invest 81:455-460, 1988.
20. 125I-labeled tumor necrosis factor: Specific binding, affinity labeling, and relationship to sensitivity. Proc Natl Acad Sci USA 82:5756-5760, 1985.
21. Tsujimoto M, Yip YK, Vilcek J: Tumor necrosis factor: Specific binding and internalization in sensitive and resistant cells. Proc Natl Acad Sci USA 82:7626-7630, 1985.
22. Wong GHW, Elwell JH, Oberley LW, Goeddel DV: Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58:923-931, 1989.